Previous Article | Next Article ![]()
Journal of Virology, October 2002, p. 9686-9694, Vol. 76, No. 19
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.19.9686-9694.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Plum Island Animal Disease Center, U.S. Department of Agriculture, Greenport, New York 11944
Received 19 March 2002/ Accepted 25 June 2002
|
|
|---|
|
|
|---|
The FMDV genome is over 8,300 bases in length and is covalently bound at its 5' terminus to a 23- to 24-amino-acid genome-linked protein, 3B. The genome encodes three copies of 3B, all of which are apparently utilized (8, 15). No natural isolates of FMDV with fewer than three 3B coding regions have been identified, suggesting that there is a strong selective pressure maintaining this redundancy, since homologous recombination within the FMDV genome (22) should readily eliminate redundant copies of 3B. Despite the observed retention of three 3Bs in all natural FMDVs, viruses lacking one of the 3Bs or with two nonfunctional 3Bs have been derived by genetic engineering (7). Recently, we have observed that viruses lacking two of the three 3Bs can be generated by similar methodology, and these "single-3B" viruses display a reduced ability to replicate in fetal bovine kidney cells, although they grow well in BHK cells and porcine kidney cells (J. M. Pacheco, T. M. Henry, and P. W. Mason, unpublished data).
Sequencing of the FMDV genome revealed a 5' untranslated region (UTR) of over 1,300 bases in length (9), longer than the UTRs found in the genomes of other picornaviruses, such as the enteroviruses (poliovirus, 740 bases [16]) and cardioviruses (encephalomyocarditis virus, 850 bases [6]). The FMDV UTR begins with a 360-base hairpin loop (the S fragment), which is separated from the remainder of the genome by a 150- to 250-nucleotide RNase T1-resistant tract containing approximately 90% C residues, with a small number of U and A residues (28). The poly(C) tract is followed by three to four tandemly repeated pseudoknots of unknown function (5) and the FMDV internal ribosome entry site (IRES) (4, 17).
Pilipenko et al. (30) derived a secondary-structure model for the 5' end of the FMDV genome by analysis of published nucleotide sequences and chemical and enzymatic treatment of RNAs derived from the same region of the genome of encephalomyocarditis virus (which has an IRES element similar to that of FMDV). This model identified five domains in the 5' UTR, including several IRES domains that have been shown to be important in binding host cell proteins, such as polypyrimidine tract-binding protein (19, 20, 23, 31) and an FMDV IRES-specific trans-activating factor, ITAF45 (31). Figure 1 shows a structure of the 5' end of the FMDV genome of serotype A12, derived from the model of Pilipenko et al. (30).
![]() View larger version (19K): [in a new window] |
FIG. 1. Two-dimensional representation of a portion of the 5' UTR of FMDV serotype A12. The structures of domains 2 to 5 are based on the model of Pilipenko et al. (30). The cre (cis-acting replicative element) and its conserved AAACA sequence (boxed) are described in the text.
|
In a subsequent study, these investigators coined the term cis-acting replicative element (cre) and demonstrated that the cre was a short hairpin loop which contained the sequence AAACA in the unpaired loop that did not require translation to exert its activity (27). Since these reports, there have been reports of similar cre structures in the genomes of other picornaviruses. Surprisingly, these elements, although apparently responsible for the same function, are located in different regions of the genomes of these other viruses: 1B in the case of three different cardioviruses (18), 2C for poliovirus (11, 34), and 2A for human rhinovirus 2 (10). Analyses of cre activity of wild-type and mutant genomes indicate that this essential structure forms in the positive-strand genome, not in the negative-strand copy (11, 27).
Recently, work on poliovirus replication suggested that the cre serves as the template for 3Dpol-mediated uridylylation of 3B (29, 34), a critical step in RNA replication, since the pUpU-3B serves as the primer for RNA synthesis. These studies showed that the cre stimulated the uridylylation of 3B by the picornaviral polymerase (3Dpol). Furthermore, the authors of these studies suggested that the conserved AAACA present in all cres identified to date (see above) serves as a template for addition of the U residues to 3B (29, 34). Since uridylylation of 3B is a requisite for RNA replication, these studies help to explain why the cre is essential for replication, but they do not explain why the activity must be supplied in cis.
Here we report the presence of a cre structure in the 5' UTR of FMDV in a region adjacent to the IRES that differs in location from a putative cre predicted to occur in the 2C region of the FMDV genome (37). Our cre structure was initially identified through its conservation among a number of different serotypes of FMDV, and its functionality was confirmed by examining the properties of viral genomes and replicons containing a panel of deliberately engineered cre mutations. Evaluation of the properties of the mutant genomes and replicons confirmed that the AAACA is absolutely required for FMDV genome replication but suggested that some changes in the stem structure could be tolerated. In addition, we found that replicating genomes and viruses could be recovered from synthetic genomes that contained an inactive (or deleted) cre in the natural 5' position and a wild-type cre added at the 3' end of the viral genome, downstream of the last coding region in the viral polyprotein.
|
|
|---|
RNA isolation, cDNA synthesis, PCR amplification, and sequencing. RNA was isolated from infected cell lysates, culture fluids harvested from infected cells, or individual viral plaques with Trizol (Life Technologies, Gaithersburg, Md.). Viral cDNAs were synthesized with Moloney murine leukemia virus reverse transcriptase (Life Technologies) with random hexamers as primers, and cDNA fragments were amplified by PCR (14) with specific oligonucleotides. PCR-amplified fragments were purified by with the Qiaquick kit (Qiagen, Valencia, Calif.) directly from the amplification reactions or from bands excised from agarose gels. Sequence analyses of these fragments were performed with selected primers and asymmetric amplification with Big-Dye terminators (ABI, Foster City, Calif.), followed by resolution on an ABI 3700 sequencer.
Construction of genome-length infectious cDNAs of type A12 containing the ß-galactosidase gene. An FMDV replicon was created from the FMDV serotype A12 genome-encoding plasmid pRMC35 by using the following strategy. A DNA fragment containing the Escherichia coli ß-galactosidase coding region was amplified by PCR (with Taq polymerase; ABI) from the pßgal-Control plasmid (Clontech, Palo Alto, Calif.) with a forward-sense oligonucleotide containing an EcoRI restriction endonuclease site present in codons 2 and 3 of the Lb form of the FMDV Lpro protein, followed by one additional Lpro codon and the first six codons of the ß-galactosidase coding region, and an antisense oligonucleotide containing an artificial XmaI site (created by silent mutation at codons 17 and 18 for the 18-amino-acid 2A protein), the entire sequence of the 2A protein, a single Gln codon from the C terminus of 1D, and seven C-terminal codons of ß-galactosidase. Following endonuclease digestion with EcoRI and XmaI, the fragment was inserted into these sites in a derivative of pRMC35 containing the artificial XmaI site in 2A, replacing the Lpro, 1A, 1B, 1C, and 1D coding regions. The resulting plasmid was sequenced through the junction regions, and 5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside staining of cells transfected with RNA transcribed from this plasmid (see below) confirmed that the replicon specified the production of ß-galactosidase.
This ß-galactosidase-containing plasmid was further modified to contain a 3' hepatitis delta virus ribozyme similar to one described previously (36). However, in this case the cleavage site was positioned to coincide precisely with the last base of the 15-nucleotide poly(A) tract, and a unique SwaI site was inserted downstream of the ribozyme. Finally, a 5'-end hammerhead ribozyme (identical to one used by Herold and Andino [12] to enhance replication by poliovirus replicons) was added to the 5' end of the FMDV S fragment of our ß-galactosidase replicon plasmid, producing a plasmid designated pA12-ßgal that could be used to produce RNA transcripts that began exactly at the predicted 5'-end UU of the viral genome and terminated with 15 A residues. The 5' end of the genome of this plasmid with the hammerhead ribozyme was transferred to plasmid pCRM4 (encoding a tissue culture-adapted form of FMDV; see above) to create a hammerhead ribozyme derivative, pCRM4H.
Mutations in the cre were made by PCR overlap mutagenesis with standard techniques (14). Following reconstitution of the mutated fragments into the genome-length clones, the sequences of the amplified regions were obtained to confirm that only the desired mutations had been inserted. To create a replicon with a shortened poly(C) tract, this portion of the genome of a plasmid containing a poly(C) tract of only two C residues was substituted for the equivalent region of pA12-ßgal. The cre was removed from the 5' end of the genome and added to the 3' end of the genome with similar PCR overlap mutagenesis procedures (14).
Derivatives of replicon plasmids that were able to transcribe RNAs capable of translation in the absence of replication were created by removing a 3,228-base fragment (precisely 1,076 codons) extending from a BglII site at codons 106 to 108 of 2B to a BamHI site at codons 273 to 275 of 3D.
In vitro RNA synthesis and transfection. Plasmids containing genome-length cDNAs were linearized at the SwaI site following the 3' hepatitis delta virus ribozyme of pA12-ßgal or StuI following the poly(A) tract of pCRM4H and used as templates for RNA synthesis with the MegaScript T7 kit (Ambion, Austin, Tex.) following the manufacturer's instructions. Transcripts were purified from unincorporated nucleotides by precipitation with LiCl and then quantitated by measuring their optical density at 260 nm. BHK cells were transfected with these synthetic RNAs by an electroporation method (24) adapted to an Electrocell Manipulator 600 (BTX Corp., San Diego, Calif.). Briefly, 0.5 ml of BHK cells at a concentration of 1.5 x 107 cells/ml in phosphate-buffered saline (PBS) were mixed with 10 µg of RNA in a 4-mm-gap BTX cuvette. The cells were then pulsed once at 330 V, infinite resistance, and a capacitance of 1,000 µF and diluted in cell growth medium, and a portion of the cells were allowed to attach to 35-mm-diameter tissue culture plates. The dead cells and medium were removed after 2.5 to 4 h, and fresh medium was added to the cultures, followed by incubation at 37°C for up to 24 h (24). In some cases, RNAs were introduced into cells with Lipofectin (Life Technologies) following the manufacturer's recommended procedures.
In vivo translation experiments. To determine whether mutated 5' UTRs could direct translation in BHK cells (in the absence of replication), truncated replicon plasmids created as described above were transfected into BHK cells along with a plasmid encoding cytomegalovirus promoter-driven bacteriophage T7 polymerase (pCB-T7). For these experiments, Lipofectamine Plus reagent (Life Technologies) was used to transfect 12.5-mm-diameter monolayers of cells with a total of 800 ng of DNA (consisting of an equimolar ratio of FMDV and T7 polymerase plasmids), as recommended by the manufacturer.
Virus recovery. Following overnight growth at 37°C, tissue culture plates containing the 35-mm-diameter monolayers of electroporated cells were frozen and thawed to lyse the cells. Ten percent of the combined lysate/culture fluid was used to infect fresh BHK monolayers, which were incubated for up to 48 h prior to freezing. In some cases, lysed monolayers from this BHK passage 1 were used to perform subsequent passages in a similar manner. In other cases, the passage 1 material was used as an inoculum to infect cells for the isolation of individual plaques, which were picked from agarose-overlaid monolayers and amplified once by growth on 35-mm-diameter monolayers by standard techniques.
ß-Galactosidase activity assay. Following electroporation of ß-galactosidase-expressing replicon RNAs or transfection of DNAs encoding truncated replicons with Lipofectamine Plus, monolayers of cells were incubated for the indicated times and then washed twice with PBS and lysed in ß-galactosidase lysis buffer (Clontech Labs, Palo Alto, Calif.). Samples were then frozen, thawed, clarified, and assayed for the presence of ß-galactosidase with a luminescent ß-galactosidase assay system, as described by the manufacturer (Clontech Labs). The units of ß-galactosidase present in each sample were determined by using a standard curve created with known concentrations of ß-galactosidase, and the protein content of each lysate was also determined (Coomassie protein assay reagent; Pierce, Rockford, Ill.), permitting expression of data as units of ß-galactosidase per nanogram of cell protein. In some cases, the protein-standardized activity was then divided by the values obtained from wild-type constructs used in side-by-side electroporations or transfections to present mutant expression as a percentage of the wild-type values.
|
|
|---|
A schematic diagram depicting the putative cre of the A12 genome is shown in Fig. 1 along with domains 2, 3, 4, and 5 drawn as derived by Pilipenko et al. (30). Interestingly, the descending strand of the stem of the cre element overlaps structural domain 1 of the 5' UTR predicted by Pilipneko et al. (30) based on computer modeling and biochemical analyses of the homologous cardiovirus 5' UTR. The domain 1 defined by Pilipenko et al. (30) has been previously shown to have little influence on the translational activity of the FMDV IRES in vitro (17), but it is often included in published representations of the FMDV IRES.
To analyze the function of the putative cre in RNA replication in the absence of viral replication and transmission, we used the ß-galactosidase-expressing replicon RNA shown in Fig. 2. Evaluation of this ß-galactosidase replicon in electroporated BHK cells showed that the replicon produced large amounts of ß-galactosidase, with a peak in activity detected approximately 12 h postelectroporation (Fig. 3). This ß-galactosidase activity was substantially reduced by the addition of guanidine HCl, which blocks FMDV multiplication (32) through inhibition of RNA synthesis, consistent with inhibition of replication with no effect on translation. However, we were not able to conclude that all of the residual ß-galactosidase activity (Fig. 3) was due to translation of the transfected RNAs, since we did not determine if the level of guanidine HCl used completely inhibited replication.
![]() View larger version (29K): [in a new window] |
FIG. 2. Schematic diagram of replicon and infectious FMDV genomes encoded by plasmids pA12-ßgal and pCRM4H, respectively. Open boxes indicate protein-coding regions, and lines indicate RNA structures. The hatched box shows the position of the E. coli ß-galactosidase-coding region in the replicon plasmid pA12-ßgal. ßgal, ß-galactosidase; S, short fragment of the genome; poly(C), polycytosine tract; PKs, pseudoknots; cre, cis-acting replicative element; IRES, internal ribosome entry site. Hairpin loop structures below the genome contain the wild-type and mutant versions of the cre, with altered nucleotides circled.
|
![]() View larger version (15K): [in a new window] |
FIG. 3. Time course of ß-galactosidase (ßgal) production by cells transfected with ß-galactosidase-expressing replicons from pA12-ßgal (wild-type cre; ), pA12-C2-ßgal (wild-type cre; ), and pA12-ßgal in the presence of 5 mM guanidine HCl ( ).
|
All replicon RNAs encoding cre mutants showed a significantly reduced ability to replicate in transfected cells (Fig. 4). Among these, the only mutant that showed activity significantly above the background level was mutant 5. To confirm that this reduction in activity was not due to an effect of these mutations on IRES-mediated translation, we evaluated the translational activity of these mutant 5' UTRs by quantitating ß-galactosidase activity in BHK cells transfected with plasmid DNAs encoding truncated genomes (Fig. 4). These data clearly show that the mutations in the cre had only modest effects on the translational activity (Fig. 4), demonstrating that these mutations exerted their effects at the level of genome replication.
![]() View larger version (31K): [in a new window] |
FIG. 4. Replication and in vivo translation activity of replicon RNAs electroporated into BHK cells and truncated replicon-derived cDNAs transfected into BHK cells, respectively. The structures of the wild-type (WT) and mutant replicons in the pA12-ßgal-derived RNAs shown along the bottom are illustrated in Fig. 2. Open bars show "in vivo" ß-galactosidase (ßgal) translation activity from the average of duplicate transfections containing equimolar amounts of plasmid DNA encoding replication-incompetent (truncated) genomes and the bacteriophage T7 polymerase (harvested 22 h posttransfection; see the text). Hatched bars show ß-galactosidase activity recovered from a single representative experiment in which cells were transfected by electroporation with 10 µg of LiCl-purified, in vitro-transcribed RNA (harvested 12 h postelectroporation; see the text).
|
To investigate the mixtures of viruses in the first passage recovered from cells transfected with RNA from pCRM4H mutant 2a, the BHK passage 1 material obtained from cells transfected with RNA containing mutation 2a was used as a source of viruses for plaque purification. Following purification, the 5' UTRs of six plaque-picked viruses were sequenced through a 475-base region commencing 15 bases downstream from the poly(C) tract (encompassing the 4 pseudoknots, the cre, and most of the IRES of these genomes). These sequence analyses revealed that one of the six plaque-purified isolates contained a mixture of genomes, while the remaining five contained one predominant genotype (no mixtures were detectable at any position).
The cre sequences detected in these five plaque isolates are shown in Fig. 5. In the case of plaques 2a.2 and 2a.4, identical sequences were revealed in the cre, although one of these isolates had point mutations within the pseudoknot region of the genome, indicating that they were separate clones. The other four plaque isolates had wild-type sequences throughout the sequenced region except for the substitutions shown in Fig. 5. Evaluation of the structures shown in Fig. 5 suggests that the stem-loop structure is a critical requirement for viral replication. Interestingly, one of the recovered plaques (plaque 2a.3) had four U residues in the mutated region, which does not appear to produce a strongly base-paired stem. However, computer folding (mFold) (25, 40) of a larger RNA sequence, extending from pseudoknot 4 through domain 2, indicated that the favored conformation of the wild-type and all four mutant 2a revertants shown in Fig. 5 formed the cre stem-loop, whereas mutants 2a and 2b (Fig. 2) did not (results not shown).
![]() View larger version (24K): [in a new window] |
FIG. 5. Predicted structures of the cres of five different plaque isolates recovered from cells transfected with a viral genome encoding cre mutant 2a. Substitutions relative to the transfected RNA are shown in lowercase letters and identified with arrowheads (wild-type and mutant 2a structures are shown at the left for comparison).
|
![]() View larger version (60K): [in a new window] |
FIG. 6. Photographs of plaques of the indicated viruses on BHK cell monolayers. Plaques from the wild-type virus (derived from pCRM4H) were produced by the second passage from the electroporated stock. Plaques from the plaque-picked isolates were produced by the BHK-amplified plaques picked from the first passage postelectroporation (this is the same passage used for the sequence analyses; see text for details).
|
![]() View larger version (24K): [in a new window] |
FIG. 7. Schematic diagram of replicon and infectious FMDV genomes showing the positions of the cre deletion (mutant 7) and the insertion of the cre at the 3' end of the genome. For this portion of the figure, lowercase letters indicate specific mutations to the genome to facilitate construction, and underlined lowercase letters indicate bases added to the genome to facilitate construction. Other abbreviations and nomenclature are explained in the legend to Fig. 2.
|
![]() View larger version (36K): [in a new window] |
FIG. 8. Photographs of plaques produced by the indicated viruses on BHK cell monolayers. Plaques for all three viruses were produced by virus recovered from the second passage of lysates of cells transfected with synthetic genome-length RNAs by using Lipofectin (see the text).
|
|
|
|---|
The cre has been identified in several picornavirus genomes, but to date it has always been found within the polyprotein-encoding region (see the introduction). However, data from McKnight and Lemon (27) indicated that translation of the sequences encoded by the human rhinovirus 14 cre element was not a requirement for genome replication. Furthermore, McKnight has recently shown that a replicating human rhinovirus 14 genome with the cre moved to the 3' end of the genome can be obtained (K. McKnight, personal communication). These data argue against a model recently proposed by Barton and coworkers, which suggests that the localization of the cre within the open reading frame contributes to the ability of the virus to control translation and replication by ensuring that the cre does not function to provide uridylylated 3B until the polyprotein-encoding region of the genome is cleared of translating ribosomes (3). Although the translation of the cre may serve as a source of this type of control for other picornaviruses, the same function must be provided by a different mechanism for FMDV, since the FMDV cre is in the 5' UTR upstream of the ribosome entry site, and the FMDV cre can also function when translocated to the 3' UTR.
On the surface, our ability to translocate the cre element from one end of the genome to the other appears to be a dramatic accomplishment. However, models for genome replication indicate that the 5' and 3' ends of the picornavirus genome are noncovalently linked to each other by host cell and viral proteins to facilitate efficient translation and replication (3, 13). Furthermore, Lyons et al. have recently demonstrated that the 5' end of the poliovirus genome is required in cis for efficient VPg uridylylation and negative-strand RNA synthesis, suggesting that the 5' and 3' ends of the genome must interact at this crucial step in the replication cycle (21). If there is a similar requirement for bringing together the 5' and 3' ends of the FMDV genome, then our ability to translocate the cre may not result in significant movement of the cre from the three-dimensional context in which it normally functions.
Data obtained in our characterization of mutated forms of genetically engineered replicons, as well as the phenotypes and genotypes of viruses recovered from mutated forms of genetically engineered viral genomes, confirmed that the FMDV cre is required for replication. Interestingly, the cre is found adjacent to the IRES, suggesting that this location could be important for orchestrating the relationship between translation and replication, although this mechanism is apparently not used by other picornaviruses which have the cre located within the polyprotein-encoding portion of their genomes (see above). Although our translation studies indicated a minimal effect of the cre mutations (including a complete deletion) on translation, it is possible that there is a subtle interaction between these contiguous replication and translation elements that is important for efficient viral replication and spread in the animal host. This supposition is consistent with the small-plaque phenotype of viruses in which the cre has been translocated to the 3' end of the genome.
This work was partially supported by the Agricultural Research Service of the USDA (CRIS Project 1940-32000-035-00D) and by a grant from the National Research Initiative Competitive Grants Program of the USDA/CSREES (grant 99-35204-7949).
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»